Cargando…
A Prospective Study of Bone Marrow Hematopoietic and Mesenchymal Stem Cells in Type 1 Gaucher Disease Patients
Gaucher disease (GD) is an autosomal recessive disorder characterized by lysosomal glucocerebrosidase (GBA) deficiency leading to hematological and skeletal manifestations. Mechanisms underlying these symptoms have not yet been elucidated. In vivo, bone marrow (BM) mesenchymal stem cells (MSCs) have...
Autores principales: | Lecourt, Séverine, Mouly, Enguerran, Freida, Delphine, Cras, Audrey, Ceccaldi, Raphaël, Heraoui, Djazia, Chomienne, Christine, Marolleau, Jean-Pierre, Arnulf, Bertrand, Porcher, Raphael, Caillaud, Catherine, Vanneaux, Valérie, Belmatoug, Nadia, Larghero, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723887/ https://www.ncbi.nlm.nih.gov/pubmed/23935976 http://dx.doi.org/10.1371/journal.pone.0069293 |
Ejemplares similares
-
Human Muscle Progenitor Cells Displayed Immunosuppressive Effect through Galectin-1 and Semaphorin-3A
por: Lecourt, Séverine, et al.
Publicado: (2012) -
Expression of transforming growth factor β receptor II in mesenchymal stem cells from systemic sclerosis patients
por: Vanneaux, Valérie, et al.
Publicado: (2013) -
The French Gaucher’s disease registry: clinical characteristics, complications and treatment of 562 patients
por: Stirnemann, Jérôme, et al.
Publicado: (2012) -
Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological model
por: Vigan, Marie, et al.
Publicado: (2014) -
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
por: Stirnemann, Jérôme, et al.
Publicado: (2017)